Search research articles
Contact Us
Filters
Showing results (341-350 of 378) with videos related to
Page
of 38
Sort By:
Urologic Oncology
|
April 15, 2017
Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy
Daniel M Tennenbaum, Brandon J Manley, Emily Zabor, et al.
Journal of Virology
|
January 9, 2009
Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness
Prasanna Jagannathan, Christine M Osborne, Cassandra Royce, et al.
Cancers
|
January 26, 2024
Multiplex Immunofluorescence Captures Progressive Immune Exhaustion with Advancing Penile Squamous Cell Cancer Stage
Filip Ionescu, Jonathan Nguyen, Carlos Moran Segura, et al.
JAMA Network Open
|
May 16, 2022
Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Nicholas H Chakiryan, L Robert Gore, Richard R Reich, et al.
Cancers
|
August 7, 2021
Geospatial Cellular Distribution of Cancer-Associated Fibroblasts Significantly Impacts Clinical Outcomes in Metastatic Clear Cell Renal Cell Carcinoma
Nicholas H Chakiryan, Gregory J Kimmel, Youngchul Kim, et al.
European Urology
|
June 19, 2022
Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma
Andrew Chang, Nicholas H Chakiryan, Dongliang Du, et al.
European Urology Focus
|
May 17, 2021
Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma
Nicholas H Chakiryan, Ali Hajiran, Youngchul Kim, et al.
The Journal of Urology
|
August 5, 2025
Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete Metastasectomy
Ali Ghasemzadeh, E Jason Abel, Jose A Karam, et al.
Research Square
|
August 13, 2025
ShinyEvents: harmonizing longitudinal data for real world survival estimation
Alyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
European Urology Focus
|
September 28, 2017
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma
Jozefina Casuscelli, Maria F Becerra, Brandon J Manley, et al.
Page
of 38
Search research articles
Search
Showing results (341-350 of 378) with videos related to
Sort By:
Page
of 38
Urologic Oncology
|
April 15, 2017
Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy
Daniel M Tennenbaum, Brandon J Manley, Emily Zabor, et al.
Journal of Virology
|
January 9, 2009
Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness
Prasanna Jagannathan, Christine M Osborne, Cassandra Royce, et al.
Cancers
|
January 26, 2024
Multiplex Immunofluorescence Captures Progressive Immune Exhaustion with Advancing Penile Squamous Cell Cancer Stage
Filip Ionescu, Jonathan Nguyen, Carlos Moran Segura, et al.
JAMA Network Open
|
May 16, 2022
Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Nicholas H Chakiryan, L Robert Gore, Richard R Reich, et al.
Cancers
|
August 7, 2021
Geospatial Cellular Distribution of Cancer-Associated Fibroblasts Significantly Impacts Clinical Outcomes in Metastatic Clear Cell Renal Cell Carcinoma
Nicholas H Chakiryan, Gregory J Kimmel, Youngchul Kim, et al.
European Urology
|
June 19, 2022
Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma
Andrew Chang, Nicholas H Chakiryan, Dongliang Du, et al.
European Urology Focus
|
May 17, 2021
Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma
Nicholas H Chakiryan, Ali Hajiran, Youngchul Kim, et al.
The Journal of Urology
|
August 5, 2025
Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete Metastasectomy
Ali Ghasemzadeh, E Jason Abel, Jose A Karam, et al.
Research Square
|
August 13, 2025
ShinyEvents: harmonizing longitudinal data for real world survival estimation
Alyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
European Urology Focus
|
September 28, 2017
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma
Jozefina Casuscelli, Maria F Becerra, Brandon J Manley, et al.
Page
of 38